These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 8612116)

  • 21. The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine.
    Balmer P; Borrow R; Arkwright PD
    Vaccine; 2007 Aug; 25(34):6321-5. PubMed ID: 17629373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
    Yu X; Gray B; Chang S; Ward JI; Edwards KM; Nahm MH
    J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.
    Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC
    J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
    Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
    J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody concentrations against the infecting serotype in vaccinated and unvaccinated children with invasive pneumococcal disease in the United Kingdom, 2006-2013.
    Brousseau N; Andrews N; Waight P; Stanford E; Newton E; Almond R; Slack MP; Miller E; Borrow R; Ladhani SN
    Clin Infect Dis; 2015 Jun; 60(12):1793-801. PubMed ID: 25737376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective antibody deficiency and its relation to the IgG2 and IgG3 subclass titers in recurrent respiratory infections.
    Sherkat R; Shoaei P; Parvaneh N; Babak A; Kassaian N
    Iran J Immunol; 2013 Mar; 10(1):55-60. PubMed ID: 23502339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia.
    Sanal O; Ersoy F; Yel L; Tezcan I; Metin A; Ozyürek H; Gariboglu S; Fikrig S; Berkel AI; Rijkers GT; Zegers BJ
    J Clin Immunol; 1999 Sep; 19(5):326-34. PubMed ID: 10535610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological responses to pneumococcal vaccine in frail older people.
    Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
    Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment.
    Stiehm ER; Roberts RL; Kaplan MS; Corren J; Jaracz E; Rico MJ
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S206-13. PubMed ID: 16021176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum concentrations of pneumococcal anticapsular antibodies in children with pneumonia associated with Streptococcus pneumonia infection.
    Esposito S; Droghetti R; Faelli N; Lastrico A; Tagliabue C; Cesati L; Bianchi C; Principi N
    Clin Infect Dis; 2003 Nov; 37(9):1261-4. PubMed ID: 14557973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
    Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
    Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.
    Bryant KA; Block SL; Baker SA; Gruber WC; Scott DA;
    Pediatrics; 2010 May; 125(5):866-75. PubMed ID: 20435707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
    Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
    J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
    McCusker C; Somerville W; Grey V; Mazer B
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal assessment of the ability of children with recurrent respiratory tract infections to produce anti-polysaccharide antibodies.
    Tuerlinckx D; Vermeulen F; Pékus V; de Bilderling G; Glupczynski Y; Collet S; Jamart J; Bodart E; Mascart F
    Clin Exp Immunol; 2007 Aug; 149(2):295-302. PubMed ID: 17511778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.
    Musher DM; Manof SB; Liss C; McFetridge RD; Marchese RD; Bushnell B; Alvarez F; Painter C; Blum MD; Silber JL
    J Infect Dis; 2010 Feb; 201(4):516-24. PubMed ID: 20092407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections.
    Sanders LA; Rijkers GT; Kuis W; Tenbergen-Meekes AJ; de Graeff-Meeder BR; Hiemstra I; Zegers BJ
    J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):110-9. PubMed ID: 8423268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral response to conjugate pneumococcal vaccine in paediatric oncology patients.
    Cheng FW; Ip M; Chu YY; Lin Z; Lee V; Shing MK; Leung WK; Yuen PM; Li CK
    Arch Dis Child; 2012 Apr; 97(4):358-60. PubMed ID: 21109505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to pneumococcal polysaccharide vaccine in children with asthma, and children with recurrent respiratory infections, and healthy children.
    Quezada A; Maggi L; Norambuena X; Inostroza J; Quevedo F
    Allergol Immunopathol (Madr); 2016; 44(4):376-81. PubMed ID: 27255476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of IgG antibodies against 13 vaccine Streptococcus pneumoniae serotypes in the Netherlands.
    Elberse KE; de Greeff SC; Wattimena N; Chew W; Schot CS; van de Pol JE; van der Heide JG; van der Ende A; van der Klis FR; Berbers GA; Schouls LM
    Vaccine; 2011 Jan; 29(5):1029-35. PubMed ID: 21129397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.